Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients

Summary

This phase II trial studies whether the nonavalent human papillomavirus vaccine given to adults prior to kidney transplantation can help the body build and maintain an effective immune response during the post-transplant period when they receive immunosuppressive drugs to prevent transplant rejection. This study will help inform our scientific understanding about vaccine-induced immune responses among immunosuppressed individuals.

Timeline

Start

2017-06-23

Primary completion

2024-03-04

Completion

2027-03-10

Drugs

Indications